Published in Neuron on February 03, 2005
Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol (2008) 1.99
75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol (2006) 1.91
Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc Natl Acad Sci U S A (2008) 1.21
Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Br J Pharmacol (2005) 1.16
The glutamate transporter EAAT5 works as a presynaptic receptor in mouse rod bipolar cells. J Physiol (2006) 1.15
Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons. J Pharmacol Exp Ther (2010) 1.03
δ-opioid receptor and somatostatin receptor-4 heterodimerization: possible implications in modulation of pain associated signaling. PLoS One (2014) 0.98
Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal. Neuron (2014) 0.97
Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nat Neurosci (2011) 0.93
micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal. J Neurosci (2010) 0.92
Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice. Br J Pharmacol (2006) 0.84
Change in functional selectivity of morphine with the development of antinociceptive tolerance. Br J Pharmacol (2014) 0.83
Opioid and GABAB receptors differentially couple to an adenylyl cyclase/protein kinase A downstream effector after chronic morphine treatment. Front Pharmacol (2014) 0.81
Contribution of adenylyl cyclase modulation of pre- and postsynaptic GABA neurotransmission to morphine antinociception and tolerance. Neuropsychopharmacology (2014) 0.81
β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons. Br J Pharmacol (2014) 0.80
Functional selectivity and time-dependence of μ-opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area. Br J Pharmacol (2014) 0.80
Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey. Br J Pharmacol (2014) 0.78
The μ-opioid receptor: an electrophysiologist's perspective from the sharp end. Br J Pharmacol (2014) 0.78
Cellular and molecular mechanisms of drug dependence: An overview and update. Indian J Psychiatry (2007) 0.76
Sex Differences in GABAA Signaling in the Periaqueductal Gray Induced by Persistent Inflammation. J Neurosci (2016) 0.76
An emerging new paradigm in opioid withdrawal: a critical role for glia-neuron signaling in the periaqueductal gray. ScientificWorldJournal (2012) 0.76
Impairment of adenylyl cyclase-mediated glutamatergic synaptic plasticity in the periaqueductal grey in a rat model of neuropathic pain. J Physiol (2015) 0.75
Endogenous opioids regulate moment-to-moment neuronal communication and excitability. Nat Commun (2017) 0.75
Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance. J Physiol (2017) 0.75
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell (2010) 7.52
Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med (2014) 5.43
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol (2006) 1.83
Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. J Biol Chem (2003) 1.78
Conus venom peptide pharmacology. Pharmacol Rev (2012) 1.69
Mu-opioid receptor desensitization: is morphine different? Br J Pharmacol (2004) 1.64
Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci (2005) 1.35
Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J Physiol (2011) 1.30
Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol (2002) 1.29
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology (2003) 1.22
Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology (2007) 1.17
Pathobiology of dynorphins in trauma and disease. Front Biosci (2005) 1.17
Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Br J Pharmacol (2005) 1.16
Two distinct mechanisms mediate acute mu-opioid receptor desensitization in native neurons. J Neurosci (2009) 1.13
Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol (2002) 1.11
Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol (2002) 1.11
Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurones. Br J Pharmacol (2009) 1.09
Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization. J Neurosci (2011) 1.09
Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J Neurosci (2002) 1.09
Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol (2011) 1.07
Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling. J Neurosci (2008) 1.04
Serotonergic and nonserotonergic dorsal raphe neurons are pharmacologically and electrophysiologically heterogeneous. J Neurophysiol (2004) 1.02
The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neurosignals (2005) 1.01
Actions of N-arachidonyl-glycine in a rat inflammatory pain model. Mol Pain (2007) 0.98
Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol (2002) 0.96
Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro. Neuropharmacology (2005) 0.94
Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nat Neurosci (2011) 0.93
Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. Mol Pharmacol (2008) 0.93
ATP potentiates neurotransmission in the rat trigeminal subnucleus caudalis. Neuroreport (2006) 0.92
Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn. J Physiol (2007) 0.92
Presynaptic gating of excitation in the dorsal raphe nucleus by GABA. Proc Natl Acad Sci U S A (2013) 0.90
Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels. J Physiol (2012) 0.89
Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effects. Eur J Pharmacol (2006) 0.89
Menthol enhances phasic and tonic GABAA receptor-mediated currents in midbrain periaqueductal grey neurons. Br J Pharmacol (2014) 0.88
Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway. J Neurosci (2009) 0.88
Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol (2003) 0.88
Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro. Neuropharmacology (2004) 0.87
Learning-related translocation of δ-opioid receptors on ventral striatal cholinergic interneurons mediates choice between goal-directed actions. J Neurosci (2013) 0.87
Multiple mechanisms of microglia: a gatekeeper's contribution to pain states. Exp Neurol (2012) 0.87
N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. Br J Pharmacol (2010) 0.86
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain (2008) 0.86
Opioid receptor modulation of GABAergic and serotonergic spinally projecting neurons of the rostral ventromedial medulla in mice. J Neurophysiol (2011) 0.86
Expression of mRNA and functional alpha(1)-adrenoceptors that suppress the GIRK conductance in adult rat locus coeruleus neurons. Br J Pharmacol (2002) 0.85
Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. Clin Exp Pharmacol Physiol (2007) 0.85
Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray. Neuropsychopharmacology (2011) 0.83
Somatostatin and nociceptin inhibit neurons in the central nucleus of amygdala that project to the periaqueductal grey. Neuropharmacology (2010) 0.82
Glutamate transporter dysfunction associated with nerve injury-induced pain in mice. J Neurophysiol (2011) 0.82
Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro. Br J Pharmacol (2004) 0.81
Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats. Neural Plast (2009) 0.81
Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain. Neurosci Lett (2005) 0.81
MrIC, a novel α-conotoxin agonist in the presence of PNU at endogenous α7 nicotinic acetylcholine receptors. Biochemistry (2013) 0.80
Prolonged stimulation of μ-opioid receptors produces β-arrestin-2-mediated heterologous desensitization of α(2)-adrenoceptor function in locus ceruleus neurons. Mol Pharmacol (2012) 0.80
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer. Clin Colorectal Cancer (2013) 0.80
Chemical synthesis and structure of the prokineticin Bv8. Chembiochem (2010) 0.79
Developmental changes in the alpha-adrenergic responses of rat periaqueductal grey neurons. Neuroreport (2003) 0.79
Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn. Mol Pain (2010) 0.79
Histochemical localisation of a galactose-containing glycoconjugate expressed by sensory neurones innervating different peripheral tissues in the rat. J Peripher Nerv Syst (2005) 0.78
Enhanced c-Fos in periaqueductal grey GABAergic neurons during opioid withdrawal. Neuroreport (2005) 0.78
μ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons. Br J Pharmacol (2014) 0.78
Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. Br J Pharmacol (2014) 0.77
Postsynaptic mGluR mediated excitation of neurons in midbrain periaqueductal grey. Neuropharmacology (2012) 0.76
Receptors: cannabis medicine without a high. Nat Chem Biol (2011) 0.75
Humanizing mice: catching up with elusive B1 receptors. Br J Pharmacol (2005) 0.75
Serotonergic modulation of neuronal activity in rat midbrain periaqueductal gray. J Neurophysiol (2013) 0.75
Cannabis constituent synergy in a mouse neuropathic pain model. Pain (2017) 0.75
Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia. Asia Pac J Clin Oncol (2012) 0.75